Trulieve Earnings + Call Notes
U.S. canna leader shares Q324 results.
$284M Revs; est. $289.4M
$96M AEBITDA; est. $86.4M
$173M GP; est. $162.7M
$.6M OI; est. $28.9M
61% GM; est. 56.2%
($61.9M) NI; est. ($18.9M)
($.32) EPS; est. ($0.17)
Q3 revenues of $284M, up 3% year over year, in line with guidance
Gross margin of 61%, compared to 52% during Q323
YTD CFO of $241 million and FCF of $162 million*
Florida adult-use campaign support of $48 million during Q3.
"As voters in Florida cast their ballots across the state today, there is an opportunity to make history by approving cannabis legalization for personal use. With 156 stores in Florida, scaled production capacity, and sufficient capital to support further investment, if approved, Trulieve is best positioned to fully prepare for the launch of recreational sales next Spring." Kim Rivers, Trulieve CEO.
Call Notes + Observations:
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.